Insurance Industry lobbying

FDA Rehires Medical Device Staffers After Mass Firings: Costly Chaos Ensues

Following mass firings at the FDA, numerous probationary staffers, primarily in medical device and food safety review, were unexpectedly reinstated. This reversal, impacting entire teams, followed industry lobbying efforts and resulted from the chaotic cost-cutting measures implemented by the administration. The reinstatements primarily affected those whose roles were partially funded by industry fees, unlike employees in other divisions, such as the tobacco center, which received no such reversal. The FDA has not yet released official figures on the number of employees fired or reinstated, but the situation highlights the significant disruption caused by the initial terminations and their subsequent reversal.

Read More

Insurance Industry Pressured DOJ to Prosecute CEO Killer as Deterrent

Following the killing of Brian Thompson, health insurance industry leaders urged the Department of Justice to prosecute accused assassin Luigi Mangione federally. This action, they argued, would deter copycat crimes. Federal charges, including potential death penalty consideration, were filed, preempting a parallel state case. The federal prosecution, seen as potentially “cleaner” than the state’s terrorism charge, is expected to proceed, though the timing suggests an effort to supersede the Manhattan District Attorney’s office. The case unfolds against a backdrop of Mangione’s anti-insurance manifesto and unexpected public support.

Read More